Skip to main content
. 2019 Aug 12;11(8):1154. doi: 10.3390/cancers11081154

Figure 1.

Figure 1

Thyroid cancer and serum levels of fibroblast growth factor 21 (FGF21). (A) The overall study design, including the numbers of participants included in this study. (B) Serum FGF21 levels in patients with papillary thyroid cancer (PTC) were significantly higher than in control subjects (* p < 0.05). (C) Serum FGF21 levels in PTC patients correlated positively with the body mass index.